Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with both functional dyspepsia (a digestive condition causing ongoing stomach discomfort) and sleep disorders, based on recognised diagnostic criteria
- People who score 7 or higher on the Pittsburgh Sleep Quality Index, a standard questionnaire used to measure sleep quality
- People who are right-handed and aged 18 years or older
- People who have not taken the following types of medications or products for at least 2 weeks before joining: antibiotics (by mouth, injection, or drip), probiotics, prebiotics, or similar gut-related supplements, any medicines that affect gut bacteria, any medicines or supplements that help with sleep or calm brain activity, or any treatments for functional dyspepsia
- People who are willing to take part voluntarily and sign a consent form agreeing to join the study
Who may not be able to join:
- People whose sleep problems are caused by medications or another medical condition
- People who also have a psychiatric disorder, or a serious heart, liver, kidney, or other major organ condition
- People who have previously received this type of treatment, or who have taken part in another clinical trial within the past 6 months
- People who have a known reaction to skin preparation materials, or who have skin damage at the area of the ear where the treatment would be applied
- People who are pregnant or currently breastfeeding
- People who have a history of brain lesions, brain surgery, or severe head trauma
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: JianNong Wu, he First Affiliated Hospital of Zhejiang Chinese Medical University
Phone: 13777571598
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The effective rate after 2-week treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.